Today's Benzinga Interviews is all about #AlcoholSubstitutes and #BiotechIndustry
Guests: Dr. Adi Zuloff-Shani, CEO of the Nasdaq-listed Israeli biotech firm developing a MEAI-based treatment for alcohol substitution and other addictive disorders, Clearmind Medicine; and Mark Haden, VP of business development at the same company as well as a longtime addiction counseling and management specialist.
Hosted by: Lara Goldstein.
